Status: current, Defined. Date: 31-Jan 2019. Module: Australian Medicines Terminology module
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 3187551000168116 | Tazac Pulvule (nizatidine 150 mg) capsule, 2 capsules, blister pack (containered trade product pack) | en | Fully specified name | Active | Case sensitive | Australian Medicines Terminology module |
| 3187561000168119 | Tazac Pulvule 150 mg capsule, 2, blister pack | en | Synonym | Active | Case sensitive | Australian Medicines Terminology module |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Tazac Pulvule 150 mg capsule, 2, blister pack | Is a | Tazac Pulvule 150 mg capsule, 2 | true | Inferred relationship | Some | ||
| Tazac Pulvule 150 mg capsule, 2, blister pack | Is a | containered trade product pack | true | Inferred relationship | Some | ||
| Tazac Pulvule 150 mg capsule, 2, blister pack | has TPUU | Tazac Pulvule (nizatidine 150 mg) capsule (trade product unit of use) | true | Inferred relationship | Some | 1 | |
| Tazac Pulvule 150 mg capsule, 2, blister pack | has container type | blister pack | true | Inferred relationship | Some | ||
| Tazac Pulvule 150 mg capsule, 2, blister pack | has TP | Tazac Pulvule | true | Inferred relationship | Some |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
Reference Sets
Australian Register of Therapeutic Goods identifier reference set (foundation metadata concept)
Containered trade product pack reference set
FHIR